Trials / Not Yet Recruiting
Not Yet RecruitingNCT06054750
Testing Regional anesthesia Techniques For Up And Early Discharge Following Knee arthroplasty - a Feasibility Study
Testing Regional anesthesia Techniques For Up And Early Discharge Following Knee arthroplasty: Quality Of Recovery Through Patient Reporting - a Feasibility Study
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 226 (estimated)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess feasibility of a a trial investigation postoperative patient-reported quality of recovery after total knee arthroplasty (TKA) with periarticular joint injection (PAI) ± single shot adductor canal block with or without adductor canal catheter infusion.
Detailed description
Knee osteoarthritis (KOA) is a leading cause of chronic knee pain and disability, with a lifetime prevalence of 45%. Treatment for symptomatic KOA includes physical therapy, oral anti-inflammatory medications and intra-articular steroid injections, with total knee arthroplasty (TKA) (or knee replacement) as the definitive treatment. Acute postoperative pain is common after TKA, leading to increased opioid consumption and increased hospital length of stay. Pain control following TKA has been investigated with interventions such as intrathecal morphine, nerve blocks, and periarticular joint injection (PAI). PAI and adductor canal block are well-established techniques used both in combination or in isolation in the management of postoperative pain for patients undergoing TKA. The aim of this study is to assess postoperative patient-reported quality of recovery after TKA with PAI and single shot adductor canal block with or without adductor canal catheter infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | 800 mg ropivacaine in continuous infusion adductor canal block (400 mL total volume) |
| DRUG | Normal saline | 400 mL normal saline in continuous infusion adductor canal block (400 mL total volume) |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2027-03-31
- Completion
- 2027-06-30
- First posted
- 2023-09-26
- Last updated
- 2024-10-22
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06054750. Inclusion in this directory is not an endorsement.